These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 17911438)
1. CD44 involvement in autoimmune inflammations: the lesson to be learned from CD44-targeting by antibody or from knockout mice. Naor D; Nedvetzki S; Walmsley M; Yayon A; Turley EA; Golan I; Caspi D; Sebban LE; Zick Y; Garin T; Karussis D; Assayag-Asherie N; Raz I; Weiss L; Slavin S; Golan I Ann N Y Acad Sci; 2007 Sep; 1110():233-47. PubMed ID: 17911438 [TBL] [Abstract][Full Text] [Related]
2. Recent advances in the regulation of CD44 expression and its role in inflammation and autoimmune diseases. Gee K; Kryworuchko M; Kumar A Arch Immunol Ther Exp (Warsz); 2004; 52(1):13-26. PubMed ID: 15053229 [TBL] [Abstract][Full Text] [Related]
3. CD44 involvement in experimental collagen-induced arthritis (CIA). Nedvetzki S; Walmsley M; Alpert E; Williams RO; Feldmann M; Naor D J Autoimmun; 1999 Aug; 13(1):39-47. PubMed ID: 10441166 [TBL] [Abstract][Full Text] [Related]
4. The mechanism of molecular redundancy in autoimmune inflammation in the context of CD44 deficiency. Naor D; Nedvetzki S; Assayag N; Thurmond RL; Huang JF; Turley EA Ann N Y Acad Sci; 2005 Jun; 1050():52-63. PubMed ID: 16014520 [TBL] [Abstract][Full Text] [Related]
5. The osteopontin - CD44 pathway is superfluous for the development of autoimmune myocarditis. Abel B; Kurrer M; Shamshiev A; Marty RR; Eriksson U; Günthert U; Kopf M Eur J Immunol; 2006 Feb; 36(2):494-9. PubMed ID: 16402410 [TBL] [Abstract][Full Text] [Related]
6. CD44 variant DNA vaccination with virtual lymph node ameliorates experimental autoimmune encephalomyelitis through the induction of apoptosis. Garin T; Rubinstein A; Grigoriadis N; Nedvetzki S; Abramsky O; Mizrachi-Koll R; Hand C; Naor D; Karussis D J Neurol Sci; 2007 Jul; 258(1-2):17-26. PubMed ID: 17382349 [TBL] [Abstract][Full Text] [Related]
7. Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody. Golan I; Nedvetzki S; Golan I; Eshkar-Sebban L; Levartovsky D; Elkayam O; Caspi D; Aamar S; Amital H; Rubinow A; Naor D J Autoimmun; 2007; 28(2-3):99-113. PubMed ID: 17383158 [TBL] [Abstract][Full Text] [Related]
8. Intervention of an inflammation amplifier, triggering receptor expressed on myeloid cells 1, for treatment of autoimmune arthritis. Murakami Y; Akahoshi T; Aoki N; Toyomoto M; Miyasaka N; Kohsaka H Arthritis Rheum; 2009 Jun; 60(6):1615-23. PubMed ID: 19479878 [TBL] [Abstract][Full Text] [Related]
9. A positive feedback loop of IL-21 signaling provoked by homeostatic CD4+CD25- T cell expansion is essential for the development of arthritis in autoimmune K/BxN mice. Jang E; Cho SH; Park H; Paik DJ; Kim JM; Youn J J Immunol; 2009 Apr; 182(8):4649-56. PubMed ID: 19342640 [TBL] [Abstract][Full Text] [Related]
11. CD44 gene vaccination for insulin-dependent diabetes mellitus in non-obese diabetic mice. Weiss L; Botero-Anug AM; Hand C; Slavin S; Naor D Isr Med Assoc J; 2008 Jan; 10(1):20-5. PubMed ID: 18300565 [TBL] [Abstract][Full Text] [Related]
12. Autoimmune regulator controls T cell help for pathogenetic autoantibody production in collagen-induced arthritis. Campbell IK; Kinkel SA; Drake SF; van Nieuwenhuijze A; Hubert FX; Tarlinton DM; Heath WR; Scott HS; Wicks IP Arthritis Rheum; 2009 Jun; 60(6):1683-93. PubMed ID: 19479827 [TBL] [Abstract][Full Text] [Related]
13. Distribution patterns of the membrane glycoprotein CD44 during the foreign-body reaction to a degradable biomaterial in rats and mice. Bonnema H; Popa ER; van Timmeren MM; van Wachem PB; de Leij LF; van Luyn MJ J Biomed Mater Res A; 2003 Mar; 64(3):502-8. PubMed ID: 12579564 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses. Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481 [TBL] [Abstract][Full Text] [Related]
15. Anti-CD44-mediated blockade of leukocyte migration in skin-associated immune diseases. Zöller M; Gupta P; Marhaba R; Vitacolonna M; Freyschmidt-Paul P J Leukoc Biol; 2007 Jul; 82(1):57-71. PubMed ID: 17442857 [TBL] [Abstract][Full Text] [Related]
16. Selective down-regulation of neutrophil Mac-1 in endotoxemic hepatic microcirculation via IL-10. Menezes GB; Lee WY; Zhou H; Waterhouse CC; Cara DC; Kubes P J Immunol; 2009 Dec; 183(11):7557-68. PubMed ID: 19917697 [TBL] [Abstract][Full Text] [Related]
17. Involvement of hyaluronan and its receptor CD44 with choroidal neovascularization. Mochimaru H; Takahashi E; Tsukamoto N; Miyazaki J; Yaguchi T; Koto T; Kurihara T; Noda K; Ozawa Y; Ishimoto T; Kawakami Y; Tanihara H; Saya H; Ishida S; Tsubota K Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4410-5. PubMed ID: 19339747 [TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid targets CD44 and inhibits FcepsilonRI signaling involving PKCdelta, Rac1, ROS, and MAPK to exert anti-allergic effect. Kim Y; Lee YS; Hahn JH; Choe J; Kwon HJ; Ro JY; Jeoung D Mol Immunol; 2008 May; 45(9):2537-47. PubMed ID: 18289679 [TBL] [Abstract][Full Text] [Related]
19. RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: a different interpretation of redundancy. Nedvetzki S; Gonen E; Assayag N; Reich R; Williams RO; Thurmond RL; Huang JF; Neudecker BA; Wang FS; Turley EA; Naor D Proc Natl Acad Sci U S A; 2004 Dec; 101(52):18081-6. PubMed ID: 15596723 [TBL] [Abstract][Full Text] [Related]
20. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion. Afify A; Purnell P; Nguyen L Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]